Mar 02, 2021 / 01:20PM GMT
Dane Vincent Leone - Raymond James & Associates, Inc., Research Division - Research Analyst
Greetings, everyone. Welcome to the 42nd Annual Raymond James Institutional Investor Conference, the second day that's starting right now. Thank you all for joining. My name is Dane Leone. I'm one of the senior biotech analysts with Raymond James. This session, I will be discussing the outlook for Bristol-Myers Squibb and joined by David Elkins, who is the Executive Vice President, Chief Financial Officer. Very excited to have David and his team joining us today for this discussion.
David, good morning to you. Thank you very much for joining us for this session today.
David V. Elkins - Bristol-Myers Squibb Company - Executive VP & CFO
Dane, thank you for having me. It's a pleasure to be here.
Dane Vincent Leone - Raymond James & Associates, Inc., Research Division - Research Analyst
Great. So the format for this discussion for everyone joining us, we're going to go through a fireside chat together. As the
Bristol-Myers Squibb Co at Raymond James Institutional Investors Conference (Virtual) Transcript
Mar 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers